Publications

Sapmaz A, Berlin I, Bos E, Wijdeven RH, Janssen H, Konietzny R, Akkermans JJ, Erson-Bensan AE, Koning RI, Kessler BM, Neefjes J, Ovaa H. USP32 regulates late endosomal transport and recycling through deubiquitylation of Rab7. Nat Commun. 2019 Mar 29;10(1):1454

Beğik O, Öyken M, Çınkıllı T, Can T, Erson-Bensan AE, Alternative Polyadenylation Patterns for Novel Gene Discovery and Classification in Cancer.  Neoplasia, 2017, 19(7), 574-582

Erson-Bensan AE, Beğik O, m6A Modification and Implications for microRNAs.  MicroRNA, 2017, 6(2), 97-101

Erson-Bensan AE. Alternative polyadenylation and RNA-binding proteins. J Mol Endocrinol. 2016 Aug;57(2):F29-34

Erson-Bensan AE, Can T. Alternative Polyadenylation: Another Foe in Cancer. Mol Cancer Res. 2016 Jun;14(6):507-17

Akman HB, Oyken M, Tuncer T, Can T, Erson-Bensan AE. 3'UTR shortening and EGF signaling: implications for breast cancer. Hum Mol Genet. 2015 Dec 15;24(24):6910-20

Akman HB, Selcuklu SD, Donoghue MT, Akhavantabasi S, Sapmaz A, Spillane C, Yakicier MC, Erson-Bensan AE. ALCAM is indirectly modulated by miR-125b in MCF7 cells. Tumour Biol. 2015 May;36(5):3511-20

Oguz Erdogan AS, Ozdemirler N, Oyken M, Alper M, Erson-Bensan AE. ARID3B expression in primary breast cancers and breast cancer-derived cell lines. Cell Oncol. 2014 Aug;37(4):289-96

Akman HB and Erson-Bensan AE. Noncoding RNAs and Cancer. TJB. 2014;38 (6): 817-828

Akman HB and Erson-Bensan AE. Alternative Polyadenylation and Its Impact on Cellular Processes. MicroRNA 2014; 3(1):2-9

Akman HB, Can T, Erson-Bensan AE.Estrogen-induced upregulation and 3'-UTR shortening of CDC6. Nucleic Acids Res. 2012 Nov 1;40(21):10679-88

Akhavantabasi S,  Sapmaz A, Tuna S, Erson-Bensan AE. miR-125b targets ARID3B in breast cancer cells. Cell Structure and Function. 2012; 37(1):27-38  

Astarci E, Erson-Bensan AE, Banerjee S. MMP16 expression is downregulated by microRNA-146a in spontaneously differentiating Caco-2 cells. Dev Growth Differ. 2012; 54(2):216-26

Ozek NS, Tuna S, Erson-Bensan AE, Severcan F. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy. Analyst. 2010 Dec 15; 135(12):3094-102

Keller JA, Erson-Bensan AE and Petty EM, Connections between CHFR, the cell cycle, and chemosensitivity: Are they critical in cancer? Cancer Biol Ther.2010 Nov 6;10(9) 942-944

Akhavantabasi S, Akman HB, Sapmaz A, Keller J, Petty EM, Erson AE, USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers. Mamm Genome. 2010 Aug;21(7-8):388-97  

Erson AE, Petty EM miRNAs and cancer: New research developments and potential clinical applications, Cancer Biology and Therapy, 2009 Dec; 8 (24): 2317 – 2322

Selcuklu SD, Yakicier MC, Erson AE. An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions. Cancer Genet Cytogenet. 2009 Feb; 189 (1):15-23

Sukas S, Erson AE, Sert C, Kulah H, A parylene based double-channel micro-electrophoresis system for rapid mutation detection via heteroduplex analysis. Electrophoresis. 2008 Sep; 29 (18):3752-3758

Erson AE, Petty EM, miRNAs in disease and development. Clinical Genetics. 2008 Oct; 74(4):296-306

Erson AE, Petty EM. CHFR-associated early G2/M checkpoint defects in breast cancer cells. Molecular Carcinogenesis. 2004 Jan, 39 (1): 26-33

Erson AE, Niell BL, DeMers SK, Rouillard JM, Hanash SM, Petty EM. Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells. Neoplasia. 2001 Nov-Dec,3(6): 521-526

Bespalova IN, Van Camp G, J H Bom S, Brown DJ, Cryns K, DeWan AT, Erson AE, Flothmann K, Kunst HP, Kurnool P, Sivakumaran TA, Cremers CW, Leal SM, Burmeister M, Lesperance MM.  Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet. 2001 Oct, 10 (22): 2501-2508

Rouillard JM, Erson AE, Kuick R, Asakawa J, Wimmer K, Muleris M, Petty EM, Hanash S. Virtual genome scan: a tool for restriction landmark-based scanning of the human genome. Genome Res. 2001 Aug, 11(8): 1453-1459